1. Home
  2. STBA vs WGS Comparison

STBA vs WGS Comparison

Compare STBA & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo S&T Bancorp Inc.

STBA

S&T Bancorp Inc.

HOLD

Current Price

$43.80

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$58.80

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
STBA
WGS
Founded
1902
2017
Country
United States
United States
Employees
N/A
1300
Industry
Major Banks
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
2.0B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
STBA
WGS
Price
$43.80
$58.80
Analyst Decision
Hold
Strong Buy
Analyst Count
6
7
Target Price
$43.00
$130.71
AVG Volume (30 Days)
197.9K
661.5K
Earning Date
04-23-2026
04-29-2026
Dividend Yield
3.23%
N/A
EPS Growth
2.35
N/A
EPS
3.49
N/A
Revenue
N/A
N/A
Revenue This Year
$10.20
$29.98
Revenue Next Year
$4.14
$25.92
P/E Ratio
$12.76
$1,251.58
Revenue Growth
N/A
N/A
52 Week Low
$32.45
$55.17
52 Week High
$44.91
$170.87

Technical Indicators

Market Signals
Indicator
STBA
WGS
Relative Strength Index (RSI) 64.07 33.00
Support Level $42.08 $55.18
Resistance Level $44.86 $95.75
Average True Range (ATR) 0.89 4.26
MACD 0.40 0.25
Stochastic Oscillator 79.22 16.20

Price Performance

Historical Comparison
STBA
WGS

About STBA S&T Bancorp Inc.

S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: